Trademarkia Logo

United Kingdom

£
Trademark Search
ingenOx

View On IPO.GOV.UK

Registered

on 29 Nov 2022

Last Applicant/ Owned by

INGENOX THERAPEUTICS LIMITED

Magdalen Centre Robert Robinson Avenue, Oxford Science Park

Oxford, , OX4 4GA

Serial Number

UK00003854372 filed on 29th Nov 2022

Registration Number

UK00003854372 registered on
24th Mar 2023

Correspondent Information

Penningtons Manches Cooper LLP

9400 Garsington Road, Oxford Business Park

Oxford,

OX4 2HN

ingenOx

epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhib Read More

Classification Information

Class [5]
Pharmaceutical Products

Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer.

Class [42]
Computer & Software Services & Scientific Services

Research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services.

Mark Details

Serial Number

UK00003854372

Mark Type

Figurative

Kind of mark

Individual